UMIN ID: UMIN000002337
Registered date:14/08/2009
Multicenter study: Effect of combined therapy using balloon-occluded arterial infusion of anticancer agent with concurrent radiation for locally invasive bladder cancer
Basic Information
| Recruitment status | Complete: follow-up continuing |
|---|---|
| Health condition(s) or Problem(s) studied | Locally invasive bladder cancer |
| Date of first enrollment | 2009/08/01 |
| Target sample size | 220 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | balloon-occluded-arterial-infusion (BOAI) of anticancer agent (cisplatin/gemcitabine), concomitant with radiation Total cystectomy |
Outcome(s)
| Primary Outcome | progression free survival |
|---|---|
| Secondary Outcome | Over all survival Quality of life incidence rate of adverse event |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Patients who : (1) had prior systemic therapy for bladder cancer (radiation or chemotherapy) (2) has serious complication (including severe DM) (3) other cancers. (4) are pregnant or wish to have baby (5) are unable to receive this treatment for some reason. |
Related Information
| Primary Sponsor | Department of Urology Osaka Medical College |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | A grant from the OMC Science Frontier Program for the Promotion of Research in Osaka Medical College |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Haruhito Azuma |
| Address | 2-7 Daigaku-cho Takatsuki-city Osaka Japan Japan |
| Telephone | 072-683-1221 |
| Affiliation | Osaka Medical College Department of Urology |
| scientific contact | |
| Name | Haruhito Azuma |
| Address | 2-7 Daigaku-cho Takatsuki-city Osaka Japan Japan |
| Telephone | 072-683-1221 |
| Affiliation | Osaka Medical College Department of Urology |